Research and development activities of TRILAB Group s.r.o. utilising technologies of 3D printing with delta kinematics for new applications of 3D printing (Q11649)

From EU Knowledge Graph
Revision as of 16:16, 28 October 2020 by DG Regio (talk | contribs) (‎Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement)
Jump to navigation Jump to search
Project Q11649 in Czech Republic
Language Label Description Also known as
English
Research and development activities of TRILAB Group s.r.o. utilising technologies of 3D printing with delta kinematics for new applications of 3D printing
Project Q11649 in Czech Republic

    Statements

    0 references
    24,982,584.55 Czech koruna
    0 references
    999,303.38 Euro
    10 January 2020
    0 references
    35,972,044.0 Czech koruna
    0 references
    1,438,881.76 Euro
    10 January 2020
    0 references
    69.45 percent
    0 references
    2 October 2017
    0 references
    30 September 2020
    0 references
    TriLAB Group s.r.o.
    0 references
    0 references

    49°13'35.62"N, 16°35'43.37"E
    0 references
    61200
    0 references
    61200
    0 references
    Žadatelem projektu je společnost TriLAB Group s.r.o., která bude v účinné spolupráci s Mikrobiologickým ústavem AV ČR, v.v.i. prostřednictvím výzkumu a vývoje směřovat k vytvoření prototypu nového produktu - řešení na bázi 3D tiskárny s Delta kinematikou pohybu hlavy a následnou aplikaci FDM tisku převážně pro oblast vědy, výzkumu, školství a průmyslu. Paraleleně bude tato technologie vyvíjena pro vědecký výzkum, biomedicínu a potravinářství. a. (Czech)
    0 references
    The applicant of the project is TRILAB Group s.r.o., which will, in effective cooperation with the Institute of Microbiology of the CAS, v.v.i., aim to create a prototype of a new product – a 3D printer-based solution with Delta head motion kinematics and subsequent application of FDM printing mainly for science, research, education and industry. In parallel, this technology will be developed for scientific research, biomedicine and food industry. a. (English)
    22 October 2020
    0 references

    Identifiers

    CZ.01.1.02/0.0/0.0/17_107/0011449
    0 references